1. (a) (b) (c) (d) (e) (f) (g) (h) Provide the word that best fits the definition for each part below. A protein on the surface of macrophages and other immune cells that recognizes and binds the constant regions of antibodies in antibody-antigen complexes. The portion of an antigen that is recognized by a particular antibody. An antibody that is produced by a hybridoma, a hybrid between a normal B cell and a B cell tumor. A pharmaceutical product that is produced from living organisms or contains components of living organisms. Description of a monoclonal antibody that has been engineered to have the original murine variable regions of the heavy and light chains coupled with human constant regions of the heavy and light chains. A generic form of a biologic drug. It is not identical in structure but identical in function, side effects, and toxicity. A new cancer therapy in which the tail end of an anti-cancer antibody is replaced by a T cell. Binding of the antibody to the tumor can activate the T cell to attack the tumor. A system of blood proteins that produces a protease cascade on activation that can lead to marking of pathogens for phagocytosis and formation of a membrane attack complex that makes holes in the surface of nearby cells.

1. (a) (b) (c) (d) (e) (f) (g) (h) Provide the word that best fits the definition for each part below. A protein on the surface of macrophages and other immune cells that recognizes and binds the constant regions of antibodies in antibody-antigen complexes. The portion of an antigen that is recognized by a particular antibody. An antibody that is produced by a hybridoma, a hybrid between a normal B cell and a B cell tumor. A pharmaceutical product that is produced from living organisms or contains components of living organisms. Description of a monoclonal antibody that has been engineered to have the original murine variable regions of the heavy and light chains coupled with human constant regions of the heavy and light chains. A generic form of a biologic drug. It is not identical in structure but identical in function, side effects, and toxicity. A new cancer therapy in which the tail end of an anti-cancer antibody is replaced by a T cell. Binding of the antibody to the tumor can activate the T cell to attack the tumor. A system of blood proteins that produces a protease cascade on activation that can lead to marking of pathogens for phagocytosis and formation of a membrane attack complex that makes holes in the surface of nearby cells.

Similar questions

B cell-receptors differ from T cell-receptors in that ________. A) B cell-receptors are immunoglobulins similar to those that are secreted, whereas T cell-receptors are not immunoglobulins and are never secreted B) T cell-receptors are much smaller than B cell-receptors C) All of the choices reflect differences between B cell- and T cell-receptors. D) B cell-receptors are comprised of four polypeptides, whereas T cell-receptors are made up of two polypeptides
Two BMI2607 students are studying for the May/June exam, when they reach a learning unit on the body’s defensive systems. One of them insists that complement is part of the nonspecific second line of defense, but the partner insists that complement is part of an antibody immune response in the third line of defense. As the third person to join them, discuss how would you explain to them that they are both correct?
How is the antibody-antigen complex (immune complex) described or characterized by affinity and avidity? (Describe what these two terms tell us about the immune complex and how are they related to each other).
The emphasis in innate immunity is that it is non-specific. Explain how two different factors/parts of the human innate immune system are not specific to a particular pathogen.” “2. Antibodies are a crucial part of adaptive immunity. Discuss the structure of an antibody and how the adaptive immune system is capable of producing different antibodies for a wide variety of antigens.” “3. The innate and adaptive immune systems typically communicate with each other. Which system acts first and then communicates with the other? Why would this be advantageous?
What type(s) of biological molecule(s) are the best at inducing immune responses? What properties make these molecules good antigens? (Remember: the biological molecules are lipids, carbohydrates, proteins, and nucleic acids)
One of the common characteristics of lymphocytes (1), neutrophils, and macrophages) the resulting immunity is not specialized b) they are the second line of defense c) they are all white cells d) they produce a cellular response
Which cleavage pattern (indicated by the red triangles in figure below) yields a fragment that has the same antigen-binding avidity as the intact antibody, but is unable to activate complement after binding to a pathogen?
Describe the genetic basis of antibody diversity.
Immune system of humans a) Secreted B cell receptors can function as opsonins. b) MHC class II molecules can be found on the surface of nearly every cell of the body. c) The membrane attack complex (MAC) is used by natural killer cells to eliminate virus infected host cells. d) Both (a) and (b) are correct and (c) is incorrect e) Statements (a), (b) and (c) are all correct
Interferons can slow down viral replication by inhibiting protein synthesis in in body cells. a.) true b.) false
3. Antibodies are valuable tools for immunological detection. Two types of antibodies are commonly used: polyclonal and monoclonal antibodies. (a) Briefly describe how polyclonal antibodies are generated. (b) Should you use a polyclonal antibody or a monoclonal antibody to bind to the antigen in the following cases below? Briefly explain your answers. (i) Immunoprecipitating a rare cellular protein in a cellular extract (ii) Detecting a protein antigen by western blotting (iii) Treating a patient with lung cancer
B cell receptor diversity is behind our ability to fight new infections. However, epitope-specific B Cell memory is critical for the secondary immune response protecting against new infections. You are ready to integrate concepts. In this question, you will combine B Cell receptor diversity and cloning! Please answer each question in less than 150 characters (including spaces). 1.Can a mature B Cell produce an epitope-specific antibody first and then switch to make an antibody against a different epitope? Explain. 2.Please describe what is transferred into an egg during cloning by somatic nuclear cell transfer. 3.How many B Cell receptors/antibodies could be generated in a mouse cloned by somatic nuclear cell transfer from a mature B Cell (after recombination)?